Psoriasis symptoms most often appear as raised, scaly patches of skin that can itch, burn, or crack, and they are a leading reason people search for answers about a long-lasting rash. Psoriasis is a chronic, immune-mediated condition in which the immune system becomes overactive and tells skin cells to multiply far too quickly, building into thick plaques. It is not contagious, and although it has no cure, it can usually be managed well. In this article you’ll learn what psoriasis looks like, its main types, what triggers flares, how it differs from eczema, when to see a doctor, the latest research, and which blood markers your clinician may track.
What are the main psoriasis symptoms?
The classic sign is a plaque: a well-defined patch of thickened skin topped with scale. On lighter skin these patches often look pink or red with silvery scale, while on brown or Black skin they may appear purple, gray, or darker brown, which can make psoriasis symptoms harder to recognize. According to the Mayo Clinic, common features include a patchy rash that varies widely between people, dry and cracked skin that may bleed, itching or soreness, and cyclic flares lasting weeks to months before easing.
Psoriasis symptoms are not limited to the skin surface. Nails can develop tiny pits, ridges, discoloration, or separation from the nail bed. Some people also notice stiff, swollen, or painful joints, which can signal psoriatic arthritis, a related condition that benefits from early attention. Because the disease tends to flare and then settle, many people have long quieter stretches between episodes.
Where psoriasis symptoms tend to appear
Plaques most commonly appear on the elbows, knees, lower back, and scalp, often symmetrically, and can also affect the face, palms, soles, genitals, and skin folds. Scalp involvement may resemble stubborn dandruff but is usually thicker and more sharply defined. When a rash is painful rather than itchy, or spreads quickly, you can consult our guide to a painful skin rash and its causes.
Types of psoriasis and their symptoms
Psoriasis is not a single pattern, and recognizing the type helps explain why psoriasis symptoms differ so much between people. The Cleveland Clinic notes that plaque psoriasis accounts for roughly 80 to 90 percent of cases, but several other forms exist:
- Plaque psoriasis: dry, raised plaques covered with scale, typically on the elbows, knees, lower back, and scalp.
- Guttate psoriasis: small, drop-shaped scaly spots, more common in children and young adults and often triggered by a streptococcal throat infection.
- Inverse psoriasis: smooth, inflamed patches in skin folds such as the groin, buttocks, and under the breasts, worsened by friction and sweat.
- Pustular psoriasis: clearly defined pus-filled bumps, sometimes limited to the palms and soles and sometimes more widespread.
- Erythrodermic psoriasis: a rare, severe form covering most of the body with a peeling, intensely itchy or burning rash that needs urgent care.
- Nail psoriasis: pitting, crumbling, discoloration, and lifting of the nail away from its bed.
What causes psoriasis, and what triggers flares?
Psoriasis is driven by an overactive immune response. Certain immune cells switch on and release signaling molecules that accelerate skin-cell turnover from the usual month down to a few days, and that speed produces the scale and thickening. Researchers believe inherited genes and environmental exposures combine to set the stage, which is why it often runs in families. To understand how the body can mistakenly target its own tissue, you can read our overview of autoimmune disease and its symptoms.
Even when the genetic groundwork is present, psoriasis symptoms may stay quiet for years until something sets them off. The NIAMS and the Mayo Clinic describe common triggers: streptococcal and other infections, skin injury such as cuts, scrapes, or sunburn, cold and dry weather, smoking, heavy alcohol use, certain medications such as lithium and some blood-pressure drugs, and abrupt corticosteroid withdrawal. Identifying your personal triggers is one of the most practical steps toward fewer flares.
Psoriasis vs eczema: how the symptoms differ
Psoriasis and eczema can look alike at first glance, and both cause discolored, itchy skin, but they are distinct conditions with different patterns of symptoms. The table below summarizes the features clinicians weigh. For a fuller picture, you can compare it with our overview of eczema as a skin condition.
| Feature | Psoriasis | Eczema |
|---|---|---|
| Appearance | Thick, well-defined plaques with silvery or gray scale | Dry, bumpy, sometimes oozing or crusted rash with less defined edges |
| Itch | Itch present but often milder; may burn or feel sore | Itching is usually intense and a leading symptom |
| Typical location | Elbows, knees, lower back, scalp, nails | Inner elbows, behind the knees, wrists, neck, face |
| Usual age of onset | Often early adulthood, though any age is possible | Frequently begins in infancy or early childhood |
| Common triggers | Infections, skin injury, stress, cold weather, certain drugs | Allergens, irritants, soaps, dry skin, environmental factors |
Itchiness alone is not a reliable way to tell them apart. To make sense of a persistent rash, you can read our explainer on skin rash causes, symptoms, and treatments. A related, eczema-type pattern is detailed in our article on spongiotic dermatitis and its treatments.
When to see a doctor about psoriasis symptoms
Psoriasis is diagnosed clinically, usually by a clinician examining the skin and, when needed, taking a small skin biopsy. Most people do not need urgent care, but some situations warrant prompt attention.
- Plaques that spread rapidly or suddenly cover a large area of the body.
- Joint pain, stiffness, or swelling that could signal psoriatic arthritis, which can damage joints if left untreated.
- Signs of an erythrodermic or pustular flare, such as widespread redness and peeling, pus-filled bumps, fever, or feeling unwell.
- A rash that becomes painful, breaks open, or shows signs of infection such as warmth, swelling, and fever.
- Symptoms that interfere with sleep, work, or emotional wellbeing, or that do not improve with treatment.
Because joint involvement is common, it helps to recognize how inflammatory joint disease behaves, so you can review our explainer on the causes and treatments of arthritis, and for the autoimmune joint pattern, our page on rheumatoid arthritis.
Why blood markers matter even though psoriasis is a skin diagnosis
Psoriasis is increasingly understood as a systemic inflammatory disease rather than a skin-only problem. Both the NIAMS and the Mayo Clinic note that people with psoriasis face a higher risk of psoriatic arthritis and of cardiometabolic conditions such as obesity, type 2 diabetes, high blood pressure, and heart disease. That is why, beyond the visible psoriasis symptoms, clinicians often monitor inflammation and metabolic health over time.
No blood test diagnoses psoriasis, but several markers help track the wider picture. Inflammation can be followed with C-reactive protein and the erythrocyte sedimentation rate, while cardiometabolic risk is assessed with a lipid panel and glucose or HbA1c. To see how a general inflammation marker behaves, you can consult our explainer on CRP as an inflammation marker, and for context on elevated readings, our page on the causes of high CRP levels. The companion test is covered in our overview of the erythrocyte sedimentation rate. Because some people are screened for overlapping conditions, you may also value our guide to the autoimmune panel and our explainer on what lupus is, alongside our review of vitamin D blood testing.
Latest scientific advances
Psoriasis care has changed substantially as researchers mapped the immune signals that drive it. Modern targeted therapies focus on interleukin-23, interleukin-17, and an enzyme called tyrosine kinase 2 (TYK2), and recent peer-reviewed studies help put their role in context. These findings describe treatments a clinician may discuss; they are not a recommendation, and decisions belong with your doctor.
A 2024 systematic literature review and network meta-analysis in Dermatology and Therapy pooled randomized controlled trials and compared bimekizumab, which blocks both interleukin-17A and interleukin-17F, with other biologics, reporting high rates of complete or near-complete skin clearance at one year. As an indirect comparison across trials, its conclusions are informative but less definitive than head-to-head data. For oral therapy, a 2025 report in the Journal of the European Academy of Dermatology and Venereology presented four-year data from the Phase 3 POETYK PSO-1, PSO-2, and long-term extension trials of deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, suggesting responses were maintained over time.
The systemic picture is also under active study. A 2026 review in the Journal of Clinical Medicine summarized the bidirectional links between psoriasis and obesity, describing shared inflammatory and metabolic pathways that can influence severity and treatment response; as a narrative review it synthesizes existing evidence rather than generating new trial data. Separately, a 2026 retrospective cohort study in the British Journal of Dermatology used real-world US data on glucagon-like peptide-1 receptor agonists in people with psoriasis who also had diabetes or obesity, reporting associations with lower cardiovascular and mortality risk. Because it is observational, it shows association rather than cause and effect. Together, these studies reinforce why monitoring inflammation and metabolic health matters.
Glossary
| Term | Definition |
|---|---|
| Plaque | A raised, well-defined patch of thickened skin covered with scale, the hallmark of plaque psoriasis. |
| Immune-mediated | Caused by the immune system reacting against the body’s own tissue rather than only outside threats. |
| Flare | A period when symptoms worsen, often after exposure to a trigger, followed by quieter spells. |
| Psoriatic arthritis | A related inflammatory joint disease causing pain, stiffness, and swelling in some people with psoriasis. |
| Erythrodermic psoriasis | A rare, severe form covering most of the body with peeling, burning skin that needs urgent care. |
| Biologic | A medication made from living cells that targets a specific immune signal, such as interleukin-17 or interleukin-23. |
| TYK2 inhibitor | An oral medicine that dampens specific cytokine signaling involved in psoriasis by acting on tyrosine kinase 2. |
| C-reactive protein | A blood marker of general inflammation that clinicians may track in inflammatory conditions. |
| HbA1c | A blood test reflecting average blood sugar over roughly three months, used to assess metabolic risk. |
Frequently asked questions
What is psoriasis?
Psoriasis is a chronic, immune-mediated skin disease in which an overactive immune response speeds up skin-cell turnover, producing thick, scaly plaques. Psoriasis symptoms commonly affect the elbows, knees, scalp, and lower back, and can also involve the nails and joints. The condition tends to cycle through flares and calmer periods. It is long-lasting and currently has no cure, but a range of treatments can control symptoms effectively, and most people manage it well with the right plan from their clinician.
What causes psoriasis?
Psoriasis results from an overactive immune system that mistakenly triggers rapid skin-cell growth. Scientists believe it stems from a mix of inherited genes and environmental factors, which is why it often runs in families. Symptoms may stay dormant until a trigger sets them off, including infections such as strep throat, skin injuries, cold or dry weather, smoking, heavy alcohol use, certain medications, and abrupt steroid withdrawal. The exact mechanism is not fully understood, but the immune pathways involved are increasingly well mapped.
Is psoriasis contagious?
No. Psoriasis is not contagious, and you cannot catch it or pass it on through skin contact, sharing items, or any other everyday interaction. Because it can look dramatic, this is a common worry, but the cause is internal: an overactive immune response combined with genetic and environmental factors. Touching someone’s plaques carries no risk of transmission, and understanding this can ease the social anxiety and stigma many people face.
Is psoriasis an autoimmune disease?
Psoriasis is widely described as an immune-mediated or autoimmune condition, because the immune system becomes overactive and drives inflammation that speeds skin-cell production. The Cleveland Clinic refers to it as an autoimmune skin condition. This systemic inflammation also helps explain why psoriasis is linked to other immune-related and cardiometabolic conditions. Recognizing the immune basis is important, since it shapes both modern targeted treatments and the decision to monitor inflammation and metabolic health beyond the skin itself.
Can psoriasis be cured?
There is currently no cure for psoriasis, but that does not mean psoriasis symptoms must be constant. Treatments ranging from topical creams to light therapy, oral medicines, and biologics can clear or greatly reduce plaques, sometimes leading to long periods of remission. The goal is effective long-term control rather than a permanent fix, and many people achieve clear or nearly clear skin with the right plan. Avoiding personal triggers and managing overall health can further reduce how often and how severely symptoms return.
Does psoriasis go away?
Psoriasis typically follows a cyclical course, flaring for weeks or months and then easing into quieter periods that can last months or years, so symptoms often come and go rather than disappearing permanently. Treatment can speed recovery from a flare and extend the calmer intervals, and remission is a realistic goal for many people. Because the underlying immune tendency remains, plaques may return after a known trigger, so ongoing care and trigger awareness help keep symptoms in check.
Sources
- Mayo Clinic. Psoriasis: Symptoms and causes. Read the Mayo Clinic overview of psoriasis (updated 2025).
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH). Psoriasis. Read the NIAMS health topic on psoriasis.
- Cleveland Clinic. Psoriasis: What It Is, Symptoms, Causes, Types and Treatment. Read the Cleveland Clinic article on psoriasis.
- Strober B, et al. Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatology and Therapy. 2024;14(11):3133-3147. PMID 39485596. Source: PubMed.
- Armstrong AW, et al. Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials. Journal of the European Academy of Dermatology and Venereology. 2025;39(7):1336-1351. PMID 40045918. Source: PubMed.
- Psoriasis in Obese Patients: Pathophysiological Interactions, Clinical Consequences, and Therapeutic Implications. Journal of Clinical Medicine. 2026;15(11). PMID 42279163. Source: PubMed.
- Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study. British Journal of Dermatology. 2026;194(1):59-66. PMID 40897378. Source: PubMed.
Further reading
- Explore our overview of eczema as a skin condition
- Read our guide to skin rash causes, symptoms, and treatments
- Learn more about autoimmune disease symptoms and causes
- See how CRP works as an inflammation marker
- Find out how to read your blood test results
Understand your lab results with AI DiagMe
Psoriasis is diagnosed on the skin, but because it reflects systemic inflammation, your clinician may track markers such as C-reactive protein, the erythrocyte sedimentation rate, a lipid panel for cholesterol, and HbA1c for blood sugar over time. AI DiagMe helps you understand what these numbers mean in plain language. It is designed to help you make sense of your results, not to diagnose, and it never replaces your doctor.
Get your results interpreted in minutes
